{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-111145","form_type":"8-K","ticker":"BGMS","cik":"0001130166","company_name":"Bio Green Med Solution, Inc.","filed_at":"2024-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.742023+00:00","generated_at":"2026-05-30T10:21:14.466263+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cyclacel gets Nasdaq extension to Dec 24, 2024 to meet equity minimum","bullets":["Nasdaq Hearing Panel granted until Dec 24, 2024 to regain compliance with Rule 5550(b)(1).","Company had stockholders' equity below $2.5 million as of June 30, 2024.","No assurance compliance will be met; delisting risk remains if not regained by deadline.","Listing Council may review panel decision within 45 days of Oct 22, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-111145","json":"https://secwatch.observer/filing/0001104659-24-111145.json","markdown":"https://secwatch.observer/filing/0001104659-24-111145.md","text":"https://secwatch.observer/filing/0001104659-24-111145.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130166/000110465924111145/0001104659-24-111145-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130166/000110465924111145/tm2426738d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:21:14.466263+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}